Inactive Instrument
3Legs Resources plc Stock London S.E.
Stocks
IM00B52P5P72
Biotechnology & Medical Research
|
End-of-day quote
London S.E.
|
||
| - GBX | - |
|
| 26/09/19 | SalvaRx Evaluates Takeover Opportunities | CI |
| 26/09/19 | Salvarx Group plc Reports Earnings Results for the Half Year Ended June 30, 2019 | CI |
| Market Cap | 1.65M 1.42M 1.33M 1.22M 2.28M 156M 2.3M 15.77M 6.14M 79.78M 6.2M 6.07M 257M | P/E 2017 |
-4.13x | P/E 2018 | 83x |
|---|---|---|---|---|---|
| Enterprise Value | 2.41M 2.08M 1.95M 1.78M 3.33M 228M 3.36M 23.06M 8.98M 117M 9.07M 8.87M 376M | EV / Sales 2017 |
-
| EV / Sales 2018 | - |
| Free-Float |
20.33% | Yield 2017 * |
-
| Yield 2018 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.41% | -2.07% | +41.26% | +95.40% | 69.02B | |
| -1.95% | -0.13% | +41.59% | +88.25% | 66.32B | |
| -0.06% | +6.79% | -11.18% | +380.05% | 27.66B | |
| +0.57% | +1.50% | +0.11% | -15.07% | 25.84B | |
| -3.00% | -2.90% | +39.40% | +9.41% | 26.54B | |
| -1.02% | +0.93% | +24.70% | -18.29% | 20.4B | |
| +3.45% | -13.46% | +222.69% | +389.50% | 17.63B | |
| -1.49% | -4.88% | -0.41% | +530.26% | 15.15B | |
| -0.84% | +7.73% | +56.93% | +163.40% | 14.65B | |
| Average | -0.45% | -1.37% | +46.12% | +180.32% | 31.47B | |
| Weighted average by Cap. | -0.59% | -0.83% | +40.97% | +140.29% |
| 2017 | 2018 | |
|---|---|---|
| Net sales | - | - |
| Net income | -1.74M -1.5M -1.41M -1.29M -2.4M -165M -2.42M -16.66M -6.49M -84.25M -6.55M -6.41M -271M | 342K 294K 276K 253K 472K 32.33M 475K 3.27M 1.27M 16.52M 1.28M 1.26M 53.21M |
| Net Debt | 2.22M 1.91M 1.79M 1.64M 3.06M 210M 3.09M 21.22M 8.27M 107M 8.34M 8.16M 346M | 763K 656K 616K 564K 1.05M 72.13M 1.06M 7.29M 2.84M 36.86M 2.87M 2.8M 119M |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
